Le Lézard
Classified in: Health, Science and technology
Subject: Conference

Ribon Therapeutics to Present at Upcoming Healthcare Conferences


Ribon Therapeutics, a clinical-stage oncology company developing first-in-class therapeutics targeting stress response pathways, today announced that Victoria Richon, Ph.D., President and CEO, will present at two upcoming virtual healthcare conferences. Presentations will consist of a panel discussion and a corporate overview.

31st Annual Cancer Progress Conference ? May 5-6, 2020
Panel: Paradigm-shifting Platforms II, Non-IO: Targeting Better, Targeting the Intractable
Date: May 5, 2020
Time: 11:45 a.m. EDT

Bank of America Securities 2020 HealthCare Conference ? May 12-14, 2020
Corporate Presentation
Date: May 12, 2020
Time: 5:00 p.m. EDT

About Ribon Therapeutics

Ribon Therapeutics is a clinical-stage biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions that contribute to disease. We are exploring novel areas of biology to develop effective treatments for patients with limited therapeutic options. Leveraging a chemical biology approach and our proprietary discovery platform, we are building a pipeline of selective, small molecule inhibitors to numerous NAD+ utilizing enzymes, beginning with monoPARPs, which have applications across multiple therapeutic areas. Our lead program is RBN-2397, a first-in-class PARP7 inhibitor in clinical development for the treatment of cancer. Ribon is located in Cambridge, Massachusetts.


These press releases may also interest you

at 20:50
Overture Launches Inner Circles: Redefining Private Attorney Referral Networks
Overture.law, the nation's leading attorney-to-attorney referral platform, launches their transformative new product, Inner Circles. This groundbreaking product empowers attorneys, law schools, bar associations, and affinity groups to build private...

at 20:09
Not Just 1, But 2: BASIS Charter Schools Celebrates a Pair of Students Named Presidential Scholars by the U.S. Department of Education
BASIS Charter Schools proudly announce that two of its exceptional students have been named 2024 U.S. Presidential Scholars by the U.S. Department of Education. Matteo N. Huish from BASIS Mesa and Sruti Peddi from BASIS Scottsdale have been...

at 20:00
Greenberg Traurigs Kemal Hawa to Moderate Panel at DICE East 2024
Kemal Hawa, co-chair of the Digital Infrastructure, Data Center and Cloud Computing Practice of global law firm Greenberg Traurig, LLP, will moderate a panel at DICE East 2024 May 22 in Reston, Virginia. Hawa, a member of the firm's Washington,...

at 19:45
WIO Taps Gracenote to Revolutionize Television Broadcast Reporting
WIO LLC, parent company of the global TV broadcast airings platform, WIOprotm, has announced a new strategic agreement with Gracenote, the global content data business unit of Nielsen, to address the longstanding challenge of accurately tracking and...

at 19:35
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

More news about Science and technology...


News published on and distributed by: